These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30582489)

  • 1. Clinical updates in aspirin-exacerbated respiratory disease.
    Laidlaw TM
    Allergy Asthma Proc; 2019 Jan; 40(1):4-6. PubMed ID: 30582489
    [No Abstract]   [Full Text] [Related]  

  • 2. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Waldram JD; Simon RA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
    Williams AN
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):657-668. PubMed ID: 27712761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
    Hill J; Burnett T; Katial R
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the management of aspirin-exacerbated respiratory disease.
    Lee JH; Jung CG; Park HS
    Expert Rev Respir Med; 2018 Feb; 12(2):137-143. PubMed ID: 29249187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin-exacerbated respiratory disease: burden of disease.
    Chang JE; White A; Simon RA; Stevenson DD
    Allergy Asthma Proc; 2012; 33(2):117-21. PubMed ID: 22525387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis.
    Stevens WW; Schleimer RP
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):669-680. PubMed ID: 27712762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease.
    Dahlin A; Weiss ST
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):765-789. PubMed ID: 27712769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
    Simon RA
    Curr Allergy Asthma Rep; 2004 Jan; 4(1):17-24. PubMed ID: 14680616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR; Ayars AG; Altman MC; Henderson WR
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
    Morales DR; Lipworth BJ; Guthrie B; Jackson C; Donnan PT; Santiago VH
    J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the epidemiology of aspirin-exacerbated respiratory disease.
    White AA
    Am J Rhinol Allergy; 2017 Sep; 31(5):299-301. PubMed ID: 28859704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin-exacerbated respiratory disease: Updates in the era of biologics.
    Mullur J; Buchheit KM
    Ann Allergy Asthma Immunol; 2023 Sep; 131(3):317-324. PubMed ID: 37225000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    Haque R; White AA; Jackson DJ; Hopkins C
    J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD; Simon RA
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.